2005
DOI: 10.1016/j.bmc.2005.03.019
|View full text |Cite
|
Sign up to set email alerts
|

A novel class of sodium/calcium exchanger inhibitor: design, synthesis, and structure–activity relationships of 3,4-dihydro-2(1H)-quinazolinone derivatives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2005
2005
2020
2020

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 24 publications
0
10
0
Order By: Relevance
“…In this system, Val-Met-Arg-Phe-NH 2 (1) and dimethylamiloride (3), which are known inhibitors of the Na (21) showed strongest activity. Since we have investigated the effects of substituents at the 3-position of the 3,4-dihydro-2(1H)-quinazolinone on the activities, 19,20) we introduced a 1-benzylpiperidin-4-yl at the 3-position of 4-phenyl-3,4-dihydropyrido [4,3-d]pyrimidin-2(1H)-one. As we anticipated, compound 26 increased the activity dramatically, showing the strong activity with an IC 30 value of 0.02 mM.…”
Section: Pharmacological Results and Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In this system, Val-Met-Arg-Phe-NH 2 (1) and dimethylamiloride (3), which are known inhibitors of the Na (21) showed strongest activity. Since we have investigated the effects of substituents at the 3-position of the 3,4-dihydro-2(1H)-quinazolinone on the activities, 19,20) we introduced a 1-benzylpiperidin-4-yl at the 3-position of 4-phenyl-3,4-dihydropyrido [4,3-d]pyrimidin-2(1H)-one. As we anticipated, compound 26 increased the activity dramatically, showing the strong activity with an IC 30 value of 0.02 mM.…”
Section: Pharmacological Results and Discussionmentioning
confidence: 99%
“…Synthesis of 4-phenyl-3,4-dihydropyrido [2,3- (20), and 4-phenyl-3,4-dihydropyrido [4,3-d]pyrimidin-2(1H)-one (21) having a N,N-diethylaminoethyl as a chain aminoalkyl group at the 3-position is illustrated in Chart 1. Trichloroacetylation of aminobenzoylpyridine 10, 21) 11, 21) and 12 21) with trichloroacetyl chloride, followed by …”
Section: Chemistrymentioning
confidence: 99%
See 1 more Smart Citation
“…Benzothiazines and 3,4-dihydroquinazoline-2-thiones are an important class of heterocyclest hat are prevalent in ag reat number of natural products and biologically activem olecules. [33][34][35][36] In this context, the Xu and Shen group developed catalyst-controlled solvent-free chemoselective syntheses of 2amino-3,1-benzothiazines 15 and 3,4-dihydroquinazoline-2-thiones 16 by using ortho-aminocinnamates 13 and isothiocyanates 14 (Scheme 11). They tested aw ide range of Lewis acids, including Yb(OTf) 3 ,S m(OTf) 3 3 ], and LiN(SiMe 3 ) 2 ,t oa ttemptt oa ttain exclusive chemoselectivity.…”
Section: Acid-catalyzed Thia-michaela Ddition Reactionsmentioning
confidence: 99%
“…811 The C4-substituted quinazolinone framework is known to exhibit a wide range of biological properties. For example, SM-15811 is a potent Na + /Ca 2+ exchanger inhibitor, 1214 proquazone is an anti-inflammatory drug, 15,16 and 4-disubstituted 3,4-dihydroquinazolinones are T-type channel selective calcium blockers with in vivo central nervous system efficacy in epilepsy and tremor models 17,18 (Figure 1). Finally, the 3,4-dihydroquinazolinones DPC 961 and DPC 083 and related analogs are potent human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors.…”
Section: Introductionmentioning
confidence: 99%